nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Simvastatin—atherosclerosis	0.0953	0.128	CbGbCtD
Metronidazole—CYP2C8—Pravastatin—atherosclerosis	0.0933	0.125	CbGbCtD
Metronidazole—CYP2C8—Lovastatin—atherosclerosis	0.0933	0.125	CbGbCtD
Metronidazole—CYP2C9—Rosuvastatin—atherosclerosis	0.0715	0.0957	CbGbCtD
Metronidazole—CYP2C9—Simvastatin—atherosclerosis	0.0665	0.0889	CbGbCtD
Metronidazole—CYP2C9—Lovastatin—atherosclerosis	0.065	0.087	CbGbCtD
Metronidazole—CYP2C9—Pravastatin—atherosclerosis	0.065	0.087	CbGbCtD
Metronidazole—CYP3A4—Rosuvastatin—atherosclerosis	0.0416	0.0556	CbGbCtD
Metronidazole—CYP3A4—Ezetimibe—atherosclerosis	0.0416	0.0556	CbGbCtD
Metronidazole—CYP3A4—Simvastatin—atherosclerosis	0.0386	0.0517	CbGbCtD
Metronidazole—CYP3A4—Pravastatin—atherosclerosis	0.0378	0.0506	CbGbCtD
Metronidazole—CYP3A4—Lovastatin—atherosclerosis	0.0378	0.0506	CbGbCtD
Metronidazole—Rhinitis—Niacin—atherosclerosis	0.000578	0.00238	CcSEcCtD
Metronidazole—Mental disorder—Ezetimibe—atherosclerosis	0.000577	0.00237	CcSEcCtD
Metronidazole—Hepatitis—Niacin—atherosclerosis	0.000577	0.00237	CcSEcCtD
Metronidazole—Flatulence—Lovastatin—atherosclerosis	0.000576	0.00237	CcSEcCtD
Metronidazole—Hypoaesthesia—Niacin—atherosclerosis	0.000574	0.00236	CcSEcCtD
Metronidazole—Erythema—Ezetimibe—atherosclerosis	0.000573	0.00236	CcSEcCtD
Metronidazole—Dysgeusia—Lovastatin—atherosclerosis	0.000572	0.00235	CcSEcCtD
Metronidazole—Rhinitis—Pravastatin—atherosclerosis	0.000569	0.00234	CcSEcCtD
Metronidazole—Hepatitis—Pravastatin—atherosclerosis	0.000568	0.00234	CcSEcCtD
Metronidazole—Confusional state—Rosuvastatin—atherosclerosis	0.000568	0.00233	CcSEcCtD
Metronidazole—Back pain—Lovastatin—atherosclerosis	0.000565	0.00233	CcSEcCtD
Metronidazole—Hypoaesthesia—Pravastatin—atherosclerosis	0.000565	0.00232	CcSEcCtD
Metronidazole—Flatulence—Ezetimibe—atherosclerosis	0.000565	0.00232	CcSEcCtD
Metronidazole—Pharyngitis—Pravastatin—atherosclerosis	0.000564	0.00232	CcSEcCtD
Metronidazole—Muscle spasms—Lovastatin—atherosclerosis	0.000562	0.00231	CcSEcCtD
Metronidazole—Infection—Rosuvastatin—atherosclerosis	0.000559	0.0023	CcSEcCtD
Metronidazole—Visual impairment—Niacin—atherosclerosis	0.000556	0.00229	CcSEcCtD
Metronidazole—Back pain—Ezetimibe—atherosclerosis	0.000555	0.00228	CcSEcCtD
Metronidazole—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000552	0.00227	CcSEcCtD
Metronidazole—Muscle spasms—Ezetimibe—atherosclerosis	0.000551	0.00227	CcSEcCtD
Metronidazole—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000551	0.00227	CcSEcCtD
Metronidazole—Vision blurred—Lovastatin—atherosclerosis	0.000551	0.00227	CcSEcCtD
Metronidazole—Mental disorder—Simvastatin—atherosclerosis	0.00055	0.00226	CcSEcCtD
Metronidazole—Tremor—Lovastatin—atherosclerosis	0.000548	0.00225	CcSEcCtD
Metronidazole—Visual impairment—Pravastatin—atherosclerosis	0.000547	0.00225	CcSEcCtD
Metronidazole—Erythema—Simvastatin—atherosclerosis	0.000547	0.00225	CcSEcCtD
Metronidazole—Eye disorder—Niacin—atherosclerosis	0.000539	0.00222	CcSEcCtD
Metronidazole—Flatulence—Simvastatin—atherosclerosis	0.000539	0.00222	CcSEcCtD
Metronidazole—Tinnitus—Niacin—atherosclerosis	0.000538	0.00221	CcSEcCtD
Metronidazole—Erythema multiforme—Pravastatin—atherosclerosis	0.000537	0.00221	CcSEcCtD
Metronidazole—Dysgeusia—Simvastatin—atherosclerosis	0.000535	0.0022	CcSEcCtD
Metronidazole—Flushing—Niacin—atherosclerosis	0.000535	0.0022	CcSEcCtD
Metronidazole—Angioedema—Lovastatin—atherosclerosis	0.000534	0.0022	CcSEcCtD
Metronidazole—Tinnitus—Pravastatin—atherosclerosis	0.000529	0.00218	CcSEcCtD
Metronidazole—Malaise—Lovastatin—atherosclerosis	0.000527	0.00217	CcSEcCtD
Metronidazole—Flushing—Pravastatin—atherosclerosis	0.000527	0.00217	CcSEcCtD
Metronidazole—Cardiac disorder—Pravastatin—atherosclerosis	0.000527	0.00217	CcSEcCtD
Metronidazole—Muscle spasms—Simvastatin—atherosclerosis	0.000526	0.00216	CcSEcCtD
Metronidazole—Vertigo—Lovastatin—atherosclerosis	0.000525	0.00216	CcSEcCtD
Metronidazole—Angioedema—Ezetimibe—atherosclerosis	0.000524	0.00215	CcSEcCtD
Metronidazole—Angiopathy—Niacin—atherosclerosis	0.000523	0.00215	CcSEcCtD
Metronidazole—Leukopenia—Lovastatin—atherosclerosis	0.000523	0.00215	CcSEcCtD
Metronidazole—Malaise—Ezetimibe—atherosclerosis	0.000517	0.00213	CcSEcCtD
Metronidazole—Vision blurred—Simvastatin—atherosclerosis	0.000515	0.00212	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000513	0.00211	CcSEcCtD
Metronidazole—Tremor—Simvastatin—atherosclerosis	0.000512	0.00211	CcSEcCtD
Metronidazole—Insomnia—Rosuvastatin—atherosclerosis	0.000509	0.00209	CcSEcCtD
Metronidazole—Palpitations—Ezetimibe—atherosclerosis	0.000507	0.00208	CcSEcCtD
Metronidazole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000505	0.00208	CcSEcCtD
Metronidazole—Erythema—Niacin—atherosclerosis	0.000502	0.00207	CcSEcCtD
Metronidazole—Angioedema—Simvastatin—atherosclerosis	0.0005	0.00205	CcSEcCtD
Metronidazole—Arthralgia—Lovastatin—atherosclerosis	0.000498	0.00205	CcSEcCtD
Metronidazole—Chest pain—Lovastatin—atherosclerosis	0.000498	0.00205	CcSEcCtD
Metronidazole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000496	0.00204	CcSEcCtD
Metronidazole—Hypertension—Ezetimibe—atherosclerosis	0.000495	0.00204	CcSEcCtD
Metronidazole—Flatulence—Niacin—atherosclerosis	0.000495	0.00203	CcSEcCtD
Metronidazole—Malaise—Simvastatin—atherosclerosis	0.000493	0.00203	CcSEcCtD
Metronidazole—Vertigo—Simvastatin—atherosclerosis	0.000491	0.00202	CcSEcCtD
Metronidazole—Leukopenia—Simvastatin—atherosclerosis	0.000489	0.00201	CcSEcCtD
Metronidazole—Arthralgia—Ezetimibe—atherosclerosis	0.000488	0.00201	CcSEcCtD
Metronidazole—Chest pain—Ezetimibe—atherosclerosis	0.000488	0.00201	CcSEcCtD
Metronidazole—Flatulence—Pravastatin—atherosclerosis	0.000487	0.002	CcSEcCtD
Metronidazole—Dry mouth—Lovastatin—atherosclerosis	0.000487	0.002	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000485	0.00199	CcSEcCtD
Metronidazole—Dysgeusia—Pravastatin—atherosclerosis	0.000484	0.00199	CcSEcCtD
Metronidazole—Muscle spasms—Niacin—atherosclerosis	0.000483	0.00199	CcSEcCtD
Metronidazole—Constipation—Rosuvastatin—atherosclerosis	0.000481	0.00198	CcSEcCtD
Metronidazole—Pain—Rosuvastatin—atherosclerosis	0.000481	0.00198	CcSEcCtD
Metronidazole—Confusional state—Lovastatin—atherosclerosis	0.000481	0.00198	CcSEcCtD
Metronidazole—Dry mouth—Ezetimibe—atherosclerosis	0.000477	0.00196	CcSEcCtD
Metronidazole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000477	0.00196	CcSEcCtD
Metronidazole—Muscle spasms—Pravastatin—atherosclerosis	0.000475	0.00195	CcSEcCtD
Metronidazole—Infection—Lovastatin—atherosclerosis	0.000474	0.00195	CcSEcCtD
Metronidazole—Vision blurred—Niacin—atherosclerosis	0.000473	0.00195	CcSEcCtD
Metronidazole—Confusional state—Ezetimibe—atherosclerosis	0.000472	0.00194	CcSEcCtD
Metronidazole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000468	0.00192	CcSEcCtD
Metronidazole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000467	0.00192	CcSEcCtD
Metronidazole—Vision blurred—Pravastatin—atherosclerosis	0.000466	0.00192	CcSEcCtD
Metronidazole—Chest pain—Simvastatin—atherosclerosis	0.000465	0.00191	CcSEcCtD
Metronidazole—Arthralgia—Simvastatin—atherosclerosis	0.000465	0.00191	CcSEcCtD
Metronidazole—Infection—Ezetimibe—atherosclerosis	0.000465	0.00191	CcSEcCtD
Metronidazole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000464	0.00191	CcSEcCtD
Metronidazole—Tremor—Pravastatin—atherosclerosis	0.000463	0.0019	CcSEcCtD
Metronidazole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00046	0.00189	CcSEcCtD
Metronidazole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000459	0.00189	CcSEcCtD
Metronidazole—Angioedema—Niacin—atherosclerosis	0.000459	0.00189	CcSEcCtD
Metronidazole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000458	0.00188	CcSEcCtD
Metronidazole—Anorexia—Lovastatin—atherosclerosis	0.000455	0.00187	CcSEcCtD
Metronidazole—Skin disorder—Ezetimibe—atherosclerosis	0.000454	0.00187	CcSEcCtD
Metronidazole—Angioedema—Pravastatin—atherosclerosis	0.000452	0.00186	CcSEcCtD
Metronidazole—Vertigo—Niacin—atherosclerosis	0.000451	0.00186	CcSEcCtD
Metronidazole—Syncope—Niacin—atherosclerosis	0.00045	0.00185	CcSEcCtD
Metronidazole—Confusional state—Simvastatin—atherosclerosis	0.00045	0.00185	CcSEcCtD
Metronidazole—Leukopenia—Niacin—atherosclerosis	0.000449	0.00185	CcSEcCtD
Metronidazole—Urticaria—Rosuvastatin—atherosclerosis	0.000447	0.00184	CcSEcCtD
Metronidazole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000446	0.00184	CcSEcCtD
Metronidazole—Oedema—Simvastatin—atherosclerosis	0.000446	0.00184	CcSEcCtD
Metronidazole—Malaise—Pravastatin—atherosclerosis	0.000446	0.00183	CcSEcCtD
Metronidazole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000445	0.00183	CcSEcCtD
Metronidazole—Vertigo—Pravastatin—atherosclerosis	0.000444	0.00183	CcSEcCtD
Metronidazole—Palpitations—Niacin—atherosclerosis	0.000444	0.00182	CcSEcCtD
Metronidazole—Infection—Simvastatin—atherosclerosis	0.000443	0.00182	CcSEcCtD
Metronidazole—Leukopenia—Pravastatin—atherosclerosis	0.000442	0.00182	CcSEcCtD
Metronidazole—Loss of consciousness—Niacin—atherosclerosis	0.000441	0.00182	CcSEcCtD
Metronidazole—Thrombocytopenia—Simvastatin—atherosclerosis	0.000437	0.0018	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000435	0.00179	CcSEcCtD
Metronidazole—Insomnia—Lovastatin—atherosclerosis	0.000431	0.00177	CcSEcCtD
Metronidazole—Paraesthesia—Lovastatin—atherosclerosis	0.000428	0.00176	CcSEcCtD
Metronidazole—Arthralgia—Niacin—atherosclerosis	0.000427	0.00176	CcSEcCtD
Metronidazole—Hypertension—Pravastatin—atherosclerosis	0.000427	0.00176	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000426	0.00175	CcSEcCtD
Metronidazole—Anorexia—Simvastatin—atherosclerosis	0.000425	0.00175	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000424	0.00175	CcSEcCtD
Metronidazole—Insomnia—Ezetimibe—atherosclerosis	0.000423	0.00174	CcSEcCtD
Metronidazole—Chest pain—Pravastatin—atherosclerosis	0.000421	0.00173	CcSEcCtD
Metronidazole—Arthralgia—Pravastatin—atherosclerosis	0.000421	0.00173	CcSEcCtD
Metronidazole—Paraesthesia—Ezetimibe—atherosclerosis	0.00042	0.00173	CcSEcCtD
Metronidazole—Dyspepsia—Lovastatin—atherosclerosis	0.00042	0.00173	CcSEcCtD
Metronidazole—Dry mouth—Niacin—atherosclerosis	0.000418	0.00172	CcSEcCtD
Metronidazole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000415	0.00171	CcSEcCtD
Metronidazole—Decreased appetite—Lovastatin—atherosclerosis	0.000415	0.00171	CcSEcCtD
Metronidazole—Dyspepsia—Ezetimibe—atherosclerosis	0.000412	0.00169	CcSEcCtD
Metronidazole—Fatigue—Lovastatin—atherosclerosis	0.000411	0.00169	CcSEcCtD
Metronidazole—Oedema—Niacin—atherosclerosis	0.00041	0.00169	CcSEcCtD
Metronidazole—Anaphylactic shock—Niacin—atherosclerosis	0.00041	0.00169	CcSEcCtD
Metronidazole—Pain—Lovastatin—atherosclerosis	0.000408	0.00168	CcSEcCtD
Metronidazole—Constipation—Lovastatin—atherosclerosis	0.000408	0.00168	CcSEcCtD
Metronidazole—Confusional state—Pravastatin—atherosclerosis	0.000407	0.00167	CcSEcCtD
Metronidazole—Decreased appetite—Ezetimibe—atherosclerosis	0.000407	0.00167	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000407	0.00167	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000404	0.00166	CcSEcCtD
Metronidazole—Asthenia—Rosuvastatin—atherosclerosis	0.000404	0.00166	CcSEcCtD
Metronidazole—Insomnia—Simvastatin—atherosclerosis	0.000404	0.00166	CcSEcCtD
Metronidazole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000403	0.00166	CcSEcCtD
Metronidazole—Oedema—Pravastatin—atherosclerosis	0.000403	0.00166	CcSEcCtD
Metronidazole—Fatigue—Ezetimibe—atherosclerosis	0.000403	0.00166	CcSEcCtD
Metronidazole—Shock—Niacin—atherosclerosis	0.000403	0.00166	CcSEcCtD
Metronidazole—Infection—Pravastatin—atherosclerosis	0.000401	0.00165	CcSEcCtD
Metronidazole—Paraesthesia—Simvastatin—atherosclerosis	0.000401	0.00165	CcSEcCtD
Metronidazole—Pain—Ezetimibe—atherosclerosis	0.0004	0.00165	CcSEcCtD
Metronidazole—Constipation—Ezetimibe—atherosclerosis	0.0004	0.00165	CcSEcCtD
Metronidazole—Pruritus—Rosuvastatin—atherosclerosis	0.000398	0.00164	CcSEcCtD
Metronidazole—Skin disorder—Niacin—atherosclerosis	0.000398	0.00164	CcSEcCtD
Metronidazole—Hyperhidrosis—Niacin—atherosclerosis	0.000396	0.00163	CcSEcCtD
Metronidazole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000395	0.00162	CcSEcCtD
Metronidazole—Feeling abnormal—Lovastatin—atherosclerosis	0.000393	0.00162	CcSEcCtD
Metronidazole—Dyspepsia—Simvastatin—atherosclerosis	0.000393	0.00162	CcSEcCtD
Metronidazole—Anorexia—Niacin—atherosclerosis	0.000391	0.00161	CcSEcCtD
Metronidazole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00039	0.0016	CcSEcCtD
Metronidazole—Hyperhidrosis—Pravastatin—atherosclerosis	0.00039	0.0016	CcSEcCtD
Metronidazole—Decreased appetite—Simvastatin—atherosclerosis	0.000388	0.0016	CcSEcCtD
Metronidazole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000386	0.00159	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000385	0.00158	CcSEcCtD
Metronidazole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000385	0.00158	CcSEcCtD
Metronidazole—Fatigue—Simvastatin—atherosclerosis	0.000385	0.00158	CcSEcCtD
Metronidazole—Anorexia—Pravastatin—atherosclerosis	0.000385	0.00158	CcSEcCtD
Metronidazole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000383	0.00157	CcSEcCtD
Metronidazole—Pain—Simvastatin—atherosclerosis	0.000382	0.00157	CcSEcCtD
Metronidazole—Constipation—Simvastatin—atherosclerosis	0.000382	0.00157	CcSEcCtD
Metronidazole—Urticaria—Lovastatin—atherosclerosis	0.000379	0.00156	CcSEcCtD
Metronidazole—Body temperature increased—Lovastatin—atherosclerosis	0.000377	0.00155	CcSEcCtD
Metronidazole—Abdominal pain—Lovastatin—atherosclerosis	0.000377	0.00155	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000373	0.00154	CcSEcCtD
Metronidazole—Dizziness—Rosuvastatin—atherosclerosis	0.000372	0.00153	CcSEcCtD
Metronidazole—Urticaria—Ezetimibe—atherosclerosis	0.000372	0.00153	CcSEcCtD
Metronidazole—Insomnia—Niacin—atherosclerosis	0.000371	0.00152	CcSEcCtD
Metronidazole—Body temperature increased—Ezetimibe—atherosclerosis	0.00037	0.00152	CcSEcCtD
Metronidazole—Abdominal pain—Ezetimibe—atherosclerosis	0.00037	0.00152	CcSEcCtD
Metronidazole—Paraesthesia—Niacin—atherosclerosis	0.000368	0.00151	CcSEcCtD
Metronidazole—Feeling abnormal—Simvastatin—atherosclerosis	0.000368	0.00151	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000368	0.00151	CcSEcCtD
Metronidazole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000365	0.0015	CcSEcCtD
Metronidazole—Insomnia—Pravastatin—atherosclerosis	0.000365	0.0015	CcSEcCtD
Metronidazole—Somnolence—Niacin—atherosclerosis	0.000364	0.0015	CcSEcCtD
Metronidazole—Paraesthesia—Pravastatin—atherosclerosis	0.000362	0.00149	CcSEcCtD
Metronidazole—Dyspepsia—Niacin—atherosclerosis	0.000361	0.00148	CcSEcCtD
Metronidazole—Decreased appetite—Niacin—atherosclerosis	0.000356	0.00147	CcSEcCtD
Metronidazole—Dyspepsia—Pravastatin—atherosclerosis	0.000355	0.00146	CcSEcCtD
Metronidazole—Rash—Rosuvastatin—atherosclerosis	0.000355	0.00146	CcSEcCtD
Metronidazole—Dermatitis—Rosuvastatin—atherosclerosis	0.000355	0.00146	CcSEcCtD
Metronidazole—Urticaria—Simvastatin—atherosclerosis	0.000354	0.00146	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000354	0.00146	CcSEcCtD
Metronidazole—Abdominal pain—Simvastatin—atherosclerosis	0.000353	0.00145	CcSEcCtD
Metronidazole—Body temperature increased—Simvastatin—atherosclerosis	0.000353	0.00145	CcSEcCtD
Metronidazole—Headache—Rosuvastatin—atherosclerosis	0.000353	0.00145	CcSEcCtD
Metronidazole—Hypersensitivity—Lovastatin—atherosclerosis	0.000351	0.00145	CcSEcCtD
Metronidazole—Decreased appetite—Pravastatin—atherosclerosis	0.000351	0.00144	CcSEcCtD
Metronidazole—Pain—Niacin—atherosclerosis	0.00035	0.00144	CcSEcCtD
Metronidazole—Fatigue—Pravastatin—atherosclerosis	0.000348	0.00143	CcSEcCtD
Metronidazole—Pain—Pravastatin—atherosclerosis	0.000345	0.00142	CcSEcCtD
Metronidazole—Constipation—Pravastatin—atherosclerosis	0.000345	0.00142	CcSEcCtD
Metronidazole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000345	0.00142	CcSEcCtD
Metronidazole—Asthenia—Lovastatin—atherosclerosis	0.000342	0.00141	CcSEcCtD
Metronidazole—Pruritus—Lovastatin—atherosclerosis	0.000338	0.00139	CcSEcCtD
Metronidazole—Asthenia—Ezetimibe—atherosclerosis	0.000336	0.00138	CcSEcCtD
Metronidazole—Gastrointestinal pain—Niacin—atherosclerosis	0.000335	0.00138	CcSEcCtD
Metronidazole—Nausea—Rosuvastatin—atherosclerosis	0.000334	0.00138	CcSEcCtD
Metronidazole—Feeling abnormal—Pravastatin—atherosclerosis	0.000332	0.00137	CcSEcCtD
Metronidazole—Pruritus—Ezetimibe—atherosclerosis	0.000331	0.00136	CcSEcCtD
Metronidazole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00033	0.00136	CcSEcCtD
Metronidazole—Hypersensitivity—Simvastatin—atherosclerosis	0.000329	0.00135	CcSEcCtD
Metronidazole—Diarrhoea—Lovastatin—atherosclerosis	0.000326	0.00134	CcSEcCtD
Metronidazole—Urticaria—Niacin—atherosclerosis	0.000325	0.00134	CcSEcCtD
Metronidazole—Abdominal pain—Niacin—atherosclerosis	0.000324	0.00133	CcSEcCtD
Metronidazole—Body temperature increased—Niacin—atherosclerosis	0.000324	0.00133	CcSEcCtD
Metronidazole—Urticaria—Pravastatin—atherosclerosis	0.00032	0.00132	CcSEcCtD
Metronidazole—Asthenia—Simvastatin—atherosclerosis	0.00032	0.00132	CcSEcCtD
Metronidazole—Diarrhoea—Ezetimibe—atherosclerosis	0.00032	0.00132	CcSEcCtD
Metronidazole—Abdominal pain—Pravastatin—atherosclerosis	0.000319	0.00131	CcSEcCtD
Metronidazole—Body temperature increased—Pravastatin—atherosclerosis	0.000319	0.00131	CcSEcCtD
Metronidazole—Pruritus—Simvastatin—atherosclerosis	0.000316	0.0013	CcSEcCtD
Metronidazole—Dizziness—Lovastatin—atherosclerosis	0.000315	0.0013	CcSEcCtD
Metronidazole—Dizziness—Ezetimibe—atherosclerosis	0.000309	0.00127	CcSEcCtD
Metronidazole—Diarrhoea—Simvastatin—atherosclerosis	0.000305	0.00126	CcSEcCtD
Metronidazole—Vomiting—Lovastatin—atherosclerosis	0.000303	0.00125	CcSEcCtD
Metronidazole—Hypersensitivity—Niacin—atherosclerosis	0.000302	0.00124	CcSEcCtD
Metronidazole—Rash—Lovastatin—atherosclerosis	0.000301	0.00124	CcSEcCtD
Metronidazole—Dermatitis—Lovastatin—atherosclerosis	0.000301	0.00124	CcSEcCtD
Metronidazole—Headache—Lovastatin—atherosclerosis	0.000299	0.00123	CcSEcCtD
Metronidazole—Vomiting—Ezetimibe—atherosclerosis	0.000298	0.00122	CcSEcCtD
Metronidazole—Hypersensitivity—Pravastatin—atherosclerosis	0.000297	0.00122	CcSEcCtD
Metronidazole—Dizziness—Simvastatin—atherosclerosis	0.000295	0.00121	CcSEcCtD
Metronidazole—Rash—Ezetimibe—atherosclerosis	0.000295	0.00121	CcSEcCtD
Metronidazole—Dermatitis—Ezetimibe—atherosclerosis	0.000295	0.00121	CcSEcCtD
Metronidazole—Asthenia—Niacin—atherosclerosis	0.000294	0.00121	CcSEcCtD
Metronidazole—Headache—Ezetimibe—atherosclerosis	0.000293	0.00121	CcSEcCtD
Metronidazole—Pruritus—Niacin—atherosclerosis	0.00029	0.00119	CcSEcCtD
Metronidazole—Asthenia—Pravastatin—atherosclerosis	0.000289	0.00119	CcSEcCtD
Metronidazole—Pruritus—Pravastatin—atherosclerosis	0.000285	0.00117	CcSEcCtD
Metronidazole—Vomiting—Simvastatin—atherosclerosis	0.000284	0.00117	CcSEcCtD
Metronidazole—Nausea—Lovastatin—atherosclerosis	0.000283	0.00117	CcSEcCtD
Metronidazole—Rash—Simvastatin—atherosclerosis	0.000281	0.00116	CcSEcCtD
Metronidazole—Dermatitis—Simvastatin—atherosclerosis	0.000281	0.00116	CcSEcCtD
Metronidazole—Diarrhoea—Niacin—atherosclerosis	0.00028	0.00115	CcSEcCtD
Metronidazole—Headache—Simvastatin—atherosclerosis	0.00028	0.00115	CcSEcCtD
Metronidazole—Nausea—Ezetimibe—atherosclerosis	0.000278	0.00114	CcSEcCtD
Metronidazole—Diarrhoea—Pravastatin—atherosclerosis	0.000276	0.00114	CcSEcCtD
Metronidazole—Dizziness—Niacin—atherosclerosis	0.000271	0.00111	CcSEcCtD
Metronidazole—Dizziness—Pravastatin—atherosclerosis	0.000267	0.0011	CcSEcCtD
Metronidazole—Nausea—Simvastatin—atherosclerosis	0.000265	0.00109	CcSEcCtD
Metronidazole—Vomiting—Niacin—atherosclerosis	0.000261	0.00107	CcSEcCtD
Metronidazole—Rash—Niacin—atherosclerosis	0.000258	0.00106	CcSEcCtD
Metronidazole—Dermatitis—Niacin—atherosclerosis	0.000258	0.00106	CcSEcCtD
Metronidazole—Headache—Niacin—atherosclerosis	0.000257	0.00106	CcSEcCtD
Metronidazole—Vomiting—Pravastatin—atherosclerosis	0.000257	0.00106	CcSEcCtD
Metronidazole—Rash—Pravastatin—atherosclerosis	0.000254	0.00105	CcSEcCtD
Metronidazole—Dermatitis—Pravastatin—atherosclerosis	0.000254	0.00105	CcSEcCtD
Metronidazole—Headache—Pravastatin—atherosclerosis	0.000253	0.00104	CcSEcCtD
Metronidazole—Nausea—Niacin—atherosclerosis	0.000243	0.001	CcSEcCtD
Metronidazole—Nausea—Pravastatin—atherosclerosis	0.00024	0.000986	CcSEcCtD
Metronidazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	7.19e-05	0.00749	CbGpPWpGaD
Metronidazole—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	7.1e-05	0.00739	CbGpPWpGaD
Metronidazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	6.65e-05	0.00693	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—GPX1—atherosclerosis	6.63e-05	0.0069	CbGpPWpGaD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	6.33e-05	0.00659	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	6.31e-05	0.00657	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP7A1—atherosclerosis	6.24e-05	0.0065	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP7A1—atherosclerosis	6.16e-05	0.00641	CbGpPWpGaD
Metronidazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	5.83e-05	0.00607	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—CYP27A1—atherosclerosis	5.77e-05	0.00601	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—CYP27A1—atherosclerosis	5.69e-05	0.00593	CbGpPWpGaD
Metronidazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	5.5e-05	0.00573	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—GPX1—atherosclerosis	5.4e-05	0.00562	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP7A1—atherosclerosis	5.08e-05	0.00529	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP7A1—atherosclerosis	5.01e-05	0.00522	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—CYP27A1—atherosclerosis	4.7e-05	0.00489	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—CYP27A1—atherosclerosis	4.63e-05	0.00482	CbGpPWpGaD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	4.39e-05	0.00457	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	4.1e-05	0.00427	CbGpPWpGaD
Metronidazole—CYP2C8—Arachidonic acid metabolism—PTGS2—atherosclerosis	3.91e-05	0.00406	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	3.86e-05	0.00402	CbGpPWpGaD
Metronidazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	3.63e-05	0.00378	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	3.35e-05	0.00349	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	3.35e-05	0.00348	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	3.35e-05	0.00348	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	3.34e-05	0.00348	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	3.31e-05	0.00344	CbGpPWpGaD
Metronidazole—CYP2C9—Arachidonic acid metabolism—PTGS2—atherosclerosis	3.18e-05	0.00331	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	3.14e-05	0.00327	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	3.1e-05	0.00322	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	3.06e-05	0.00318	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	2.72e-05	0.00283	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	2.72e-05	0.00283	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	2.64e-05	0.00275	CbGpPWpGaD
Metronidazole—CYP2C8—Biological oxidations—GSTM1—atherosclerosis	2.58e-05	0.00268	CbGpPWpGaD
Metronidazole—CYP2C8—Metapathway biotransformation—GSTM1—atherosclerosis	2.54e-05	0.00265	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	2.49e-05	0.00259	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	2.49e-05	0.00259	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	2.44e-05	0.00254	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	2.4e-05	0.0025	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	2.22e-05	0.00231	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	2.15e-05	0.00224	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.1e-05	0.00219	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.1e-05	0.00219	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.1e-05	0.00219	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.1e-05	0.00219	CbGpPWpGaD
Metronidazole—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	2.1e-05	0.00218	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	2.08e-05	0.00216	CbGpPWpGaD
Metronidazole—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	2.07e-05	0.00215	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	2.02e-05	0.00211	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	2.02e-05	0.00211	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2e-05	0.00209	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	1.99e-05	0.00207	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	1.95e-05	0.00203	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.92e-05	0.002	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.85e-05	0.00193	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LDLRAP1—atherosclerosis	1.83e-05	0.0019	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	1.8e-05	0.00188	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.79e-05	0.00186	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PLTP—atherosclerosis	1.72e-05	0.00179	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	1.71e-05	0.00178	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	1.71e-05	0.00178	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	1.71e-05	0.00178	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	1.71e-05	0.00178	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	1.69e-05	0.00176	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.63e-05	0.0017	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.59e-05	0.00166	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.58e-05	0.00165	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.57e-05	0.00164	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.56e-05	0.00163	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.54e-05	0.0016	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.51e-05	0.00157	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCG8—atherosclerosis	1.49e-05	0.00155	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LTA4H—atherosclerosis	1.49e-05	0.00155	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	1.49e-05	0.00155	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.47e-05	0.00153	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.45e-05	0.00151	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PLTP—atherosclerosis	1.4e-05	0.00146	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.39e-05	0.00145	CbGpPWpGaD
Metronidazole—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.38e-05	0.00144	CbGpPWpGaD
Metronidazole—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.36e-05	0.00142	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.3e-05	0.00135	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.29e-05	0.00134	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.28e-05	0.00133	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.25e-05	0.0013	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.24e-05	0.00129	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.21e-05	0.00126	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.21e-05	0.00126	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.2e-05	0.00125	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCG1—atherosclerosis	1.18e-05	0.00123	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.13e-05	0.00118	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—FABP4—atherosclerosis	1.11e-05	0.00115	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LCAT—atherosclerosis	1.11e-05	0.00115	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOA4—atherosclerosis	1.09e-05	0.00113	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP7A1—atherosclerosis	1.07e-05	0.00111	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.02e-05	0.00106	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.01e-05	0.00105	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CYP27A1—atherosclerosis	9.87e-06	0.00103	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	9.81e-06	0.00102	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.72e-06	0.00101	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCG1—atherosclerosis	9.59e-06	0.000998	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.48e-06	0.000987	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	9.36e-06	0.000974	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALOX15—atherosclerosis	9.36e-06	0.000974	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOA2—atherosclerosis	9.36e-06	0.000974	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	9.36e-06	0.000974	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCG5—atherosclerosis	9.24e-06	0.000962	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.23e-06	0.000961	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PLTP—atherosclerosis	9.22e-06	0.00096	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—FABP4—atherosclerosis	9.01e-06	0.000938	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LCAT—atherosclerosis	9.01e-06	0.000938	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LPA—atherosclerosis	8.93e-06	0.000929	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOA4—atherosclerosis	8.85e-06	0.000921	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP7A1—atherosclerosis	8.69e-06	0.000905	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—BGN—atherosclerosis	8.65e-06	0.0009	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.58e-06	0.000893	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOA5—atherosclerosis	8.56e-06	0.000891	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.31e-06	0.000865	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	8.28e-06	0.000862	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	8.24e-06	0.000857	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.15e-06	0.000848	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.07e-06	0.00084	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.05e-06	0.000838	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CYP27A1—atherosclerosis	8.03e-06	0.000836	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LTA4H—atherosclerosis	8e-06	0.000832	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCG8—atherosclerosis	8e-06	0.000832	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALOX5—atherosclerosis	7.96e-06	0.000828	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.91e-06	0.000823	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.72e-06	0.000803	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	7.62e-06	0.000793	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOA2—atherosclerosis	7.62e-06	0.000793	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALOX15—atherosclerosis	7.62e-06	0.000793	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	7.62e-06	0.000793	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCG5—atherosclerosis	7.52e-06	0.000783	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	7.51e-06	0.000782	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.35e-06	0.000765	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LPA—atherosclerosis	7.27e-06	0.000756	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NAMPT—atherosclerosis	7.14e-06	0.000743	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.09e-06	0.000738	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LIPC—atherosclerosis	7.09e-06	0.000738	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOC3—atherosclerosis	7.05e-06	0.000734	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—BGN—atherosclerosis	7.04e-06	0.000732	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LDLR—atherosclerosis	7.01e-06	0.000729	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.99e-06	0.000727	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOA5—atherosclerosis	6.97e-06	0.000725	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CETP—atherosclerosis	6.84e-06	0.000712	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.77e-06	0.000704	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.71e-06	0.000698	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.63e-06	0.00069	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.57e-06	0.000684	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.55e-06	0.000682	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—SCARB1—atherosclerosis	6.55e-06	0.000682	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALOX5—atherosclerosis	6.48e-06	0.000674	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.38e-06	0.000664	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCG1—atherosclerosis	6.32e-06	0.000658	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HMGCR—atherosclerosis	6.19e-06	0.000644	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.98e-06	0.000623	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—FABP4—atherosclerosis	5.94e-06	0.000619	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LCAT—atherosclerosis	5.94e-06	0.000619	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOA4—atherosclerosis	5.83e-06	0.000607	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.81e-06	0.000605	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.77e-06	0.000601	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LIPC—atherosclerosis	5.77e-06	0.000601	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOC3—atherosclerosis	5.74e-06	0.000597	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.73e-06	0.000597	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LDLR—atherosclerosis	5.7e-06	0.000593	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.58e-06	0.000581	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CETP—atherosclerosis	5.57e-06	0.00058	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ABCA1—atherosclerosis	5.52e-06	0.000574	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—SCARB1—atherosclerosis	5.33e-06	0.000555	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CYP27A1—atherosclerosis	5.3e-06	0.000551	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.19e-06	0.00054	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HMGCR—atherosclerosis	5.04e-06	0.000524	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.02e-06	0.000523	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOA2—atherosclerosis	5.02e-06	0.000523	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.02e-06	0.000523	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.02e-06	0.000523	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.96e-06	0.000516	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LPA—atherosclerosis	4.79e-06	0.000499	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—HMOX1—atherosclerosis	4.73e-06	0.000492	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—BGN—atherosclerosis	4.64e-06	0.000483	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOA5—atherosclerosis	4.59e-06	0.000478	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.54e-06	0.000473	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOB—atherosclerosis	4.53e-06	0.000472	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.49e-06	0.000467	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.42e-06	0.00046	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.41e-06	0.000459	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—LPL—atherosclerosis	4.33e-06	0.00045	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.27e-06	0.000445	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—GPX1—atherosclerosis	4.22e-06	0.000439	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CD36—atherosclerosis	4.11e-06	0.000428	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—MTHFR—atherosclerosis	3.9e-06	0.000406	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.85e-06	0.000401	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.83e-06	0.000399	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPARA—atherosclerosis	3.82e-06	0.000398	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LIPC—atherosclerosis	3.81e-06	0.000396	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOC3—atherosclerosis	3.78e-06	0.000394	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LDLR—atherosclerosis	3.76e-06	0.000391	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AGT—atherosclerosis	3.7e-06	0.000385	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOB—atherosclerosis	3.69e-06	0.000384	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CETP—atherosclerosis	3.67e-06	0.000382	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOE—atherosclerosis	3.63e-06	0.000378	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—CAV1—atherosclerosis	3.59e-06	0.000374	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.59e-06	0.000373	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—APOA1—atherosclerosis	3.59e-06	0.000373	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—LPL—atherosclerosis	3.52e-06	0.000367	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.52e-06	0.000366	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—GPX1—atherosclerosis	3.44e-06	0.000358	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CD36—atherosclerosis	3.35e-06	0.000348	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.32e-06	0.000346	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.27e-06	0.000341	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—MTHFR—atherosclerosis	3.17e-06	0.00033	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PPARG—atherosclerosis	3.16e-06	0.000329	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPARA—atherosclerosis	3.11e-06	0.000324	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—INS—atherosclerosis	3.1e-06	0.000323	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AGT—atherosclerosis	3.01e-06	0.000314	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.96e-06	0.000308	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOE—atherosclerosis	2.95e-06	0.000307	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—CAV1—atherosclerosis	2.93e-06	0.000304	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—APOA1—atherosclerosis	2.92e-06	0.000304	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—ALB—atherosclerosis	2.84e-06	0.000296	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—NOS3—atherosclerosis	2.72e-06	0.000283	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.66e-06	0.000277	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PPARG—atherosclerosis	2.57e-06	0.000268	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.54e-06	0.000264	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—INS—atherosclerosis	2.52e-06	0.000263	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.49e-06	0.000259	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOB—atherosclerosis	2.43e-06	0.000253	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.37e-06	0.000246	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—LPL—atherosclerosis	2.32e-06	0.000242	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—ALB—atherosclerosis	2.31e-06	0.000241	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—GPX1—atherosclerosis	2.27e-06	0.000236	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—NOS3—atherosclerosis	2.21e-06	0.00023	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CD36—atherosclerosis	2.21e-06	0.00023	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.09e-06	0.000218	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPARA—atherosclerosis	2.05e-06	0.000214	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.02e-06	0.000211	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AGT—atherosclerosis	1.99e-06	0.000207	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOE—atherosclerosis	1.95e-06	0.000203	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—CAV1—atherosclerosis	1.93e-06	0.000201	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—APOA1—atherosclerosis	1.92e-06	0.0002	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.76e-06	0.000183	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PPARG—atherosclerosis	1.7e-06	0.000177	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—INS—atherosclerosis	1.66e-06	0.000173	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—ALB—atherosclerosis	1.52e-06	0.000159	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—NOS3—atherosclerosis	1.46e-06	0.000152	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.33e-06	0.000139	CbGpPWpGaD
Metronidazole—CYP2C8—Metabolism—AKT1—atherosclerosis	1.25e-06	0.00013	CbGpPWpGaD
Metronidazole—CYP2C9—Metabolism—AKT1—atherosclerosis	1.02e-06	0.000106	CbGpPWpGaD
Metronidazole—CYP3A4—Metabolism—AKT1—atherosclerosis	6.71e-07	6.98e-05	CbGpPWpGaD
